Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marjolein van Egmond

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Expert Opinion on Biological Therapy|December 18, 2007
Neutrophils in antibody-based immunotherapy of cancerMarjolein van Egmond
Cancer Research|November 18, 2015
Antibody-Dependent Phagocytosis of Tumor Cells by Macrophages: A Potent Effector Mechanism of Monoclonal Antibody Therapy of CancerNuray Gül, Marjolein van Egmond
Frontiers in Immunology|April 16, 2019
IgA and FcαRI: Pathological Roles and Therapeutic OpportunitiesAnnelot Breedveld, Marjolein van Egmond
European Journal of Clinical Investigation|June 2, 2018
Monoclonal antibody-mediated killing of tumour cells by neutrophilsNiels Heemskerk, Marjolein van Egmond
Mabs|June 22, 2011
Immunoglobulin A: A next generation of therapeutic antibodies?Jantine E Bakema, Marjolein van Egmond
European Journal of Clinical Investigation|December 27, 2016
Immunoglobulin A: magic bullet or Trojan horse?Marieke H Heineke, Marjolein van Egmond
Immunology Letters|April 15, 2004
The Fc receptor for IgA (FcalphaRI, CD89)Marielle A Otten, Marjolein van Egmond
Current Topics in Microbiology and Immunology|August 14, 2014
Fc receptor-dependent mechanisms of monoclonal antibody therapy of cancerJantine E Bakema, Marjolein van Egmond
Seminars in Cancer Biology|January 5, 2013
Neutrophils as effector cells for antibody-based immunotherapy of cancerMarjolein van Egmond, Jantine E Bakema
Cellular and Molecular Life Sciences : CMLS|November 27, 2022
Mechanisms of colorectal liver metastasis developmentTal Shasha, Mandy Gruijs, Marjolein van Egmond
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Expert Opinion on Biological Therapy|December 18, 2007
Neutrophils in antibody-based immunotherapy of cancerMarjolein van Egmond
Cancer Research|November 18, 2015
Antibody-Dependent Phagocytosis of Tumor Cells by Macrophages: A Potent Effector Mechanism of Monoclonal Antibody Therapy of CancerNuray Gül, Marjolein van Egmond
Frontiers in Immunology|April 16, 2019
IgA and FcαRI: Pathological Roles and Therapeutic OpportunitiesAnnelot Breedveld, Marjolein van Egmond
European Journal of Clinical Investigation|June 2, 2018
Monoclonal antibody-mediated killing of tumour cells by neutrophilsNiels Heemskerk, Marjolein van Egmond
Mabs|June 22, 2011
Immunoglobulin A: A next generation of therapeutic antibodies?Jantine E Bakema, Marjolein van Egmond
European Journal of Clinical Investigation|December 27, 2016
Immunoglobulin A: magic bullet or Trojan horse?Marieke H Heineke, Marjolein van Egmond
Immunology Letters|April 15, 2004
The Fc receptor for IgA (FcalphaRI, CD89)Marielle A Otten, Marjolein van Egmond
Current Topics in Microbiology and Immunology|August 14, 2014
Fc receptor-dependent mechanisms of monoclonal antibody therapy of cancerJantine E Bakema, Marjolein van Egmond
Seminars in Cancer Biology|January 5, 2013
Neutrophils as effector cells for antibody-based immunotherapy of cancerMarjolein van Egmond, Jantine E Bakema
Cellular and Molecular Life Sciences : CMLS|November 27, 2022
Mechanisms of colorectal liver metastasis developmentTal Shasha, Mandy Gruijs, Marjolein van Egmond
Pageof 10